Michael Goldbrunner

Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

Johanna C. Bendell, Jordi Rodón, Howard A. Burris et al. · Journal of Clinical Oncology · 2011 · 679 citations · Full text

Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen et al. · Oligonucleotides · 2007 · 217 citations

Inhibition of Tubulin Polymerization by 5,6-Dihydroindolo[2,1-<i>a</i>]isoquinoline Derivatives

Michael Goldbrunner, Günther Loidl, Thomas Polossek et al. · Journal of Medicinal Chemistry · 1997 · 146 citations · Full text

Pharmaceutical Science, Chemoprevention Strategy, Tubulin System +16

Methoxy-Substituted 3-Formyl-2-phenylindoles Inhibit Tubulin Polymerization

Robert Gastpar, Michael Goldbrunner, Doris Marko et al. · Journal of Medicinal Chemistry · 1998 · 124 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Chemoprevention Strategy +16

Intracerebral and Intrathecal Infusion of the TGF-β2-Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety

Reimar Schlingensiepen, Michael Goldbrunner, Mara Szyrach et al. · Oligonucleotides · 2005 · 68 citations

Neuro-oncology, Oncology, Ap 12009 +12